Literature DB >> 19078795

Self-reported Pain Affects Quality of Life in Myasthenia Gravis.

Kevin R Scott1, Milind J Kothari.   

Abstract

Entities:  

Year:  2006        PMID： 19078795     DOI： 10.1097/01.cnd.0000202223.39994.c0

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN： 1522-0443


× No keyword cloud information.
  6 in total

1.  Quality of life and life circumstances in German myasthenia gravis patients.

Authors:  Sabine Twork; Susanne Wiesmeth; Jörg Klewer; Dieter Pöhlau; Joachim Kugler
Journal:  Health Qual Life Outcomes       Date:  2010-11-11       Impact factor: 3.186

Review 2.  Pain, Headache, and Other Non-motor Symptoms in Myasthenia Gravis.

Authors:  Olivia Tong; Leslie Delfiner; Steven Herskovitz
Journal:  Curr Pain Headache Rep       Date:  2018-05-03

3.  Validation of the MG-DIS: a disability assessment for myasthenia gravis.

Authors:  Alberto Raggi; Matilde Leonardi; Silvia Schiavolin; Carlo Antozzi; Greta Brenna; Lorenzo Maggi; Renato Mantegazza
Journal:  J Neurol       Date:  2016-03-01       Impact factor: 4.849

4.  Concordance between severity of disease, disability and health-related quality of life in myasthenia gravis.

Authors:  Alberto Raggi; Matilde Leonardi; Carlo Antozzi; Paolo Confalonieri; Lorenzo Maggi; Ferdinando Cornelio; Renato Mantegazza
Journal:  Neurol Sci       Date:  2009-10-09       Impact factor: 3.307

5.  Labour market participation and sick leave among patients diagnosed with myasthenia gravis in Denmark 1997-2011: a Danish nationwide cohort study.

Authors:  Asger Frost; Marie Louise Svendsen; Jes Rahbek; Christina Malmose Stapelfeldt; Claus Vinther Nielsen; Thomas Lund
Journal:  BMC Neurol       Date:  2016-11-17       Impact factor: 2.474

6.  Determinants of quality of life in Brazilian patients with myasthenia gravis.

Authors:  Aline Mansueto Mourão; Rodrigo Santiago Gomez; Luiz Sergio Mageste Barbosa; Denise da Silva Freitas; Elizabeth Regina Comini-Frota; Arthur Kummer; Stella Maris Aguiar Lemos; Antonio Lucio Teixeira
Journal:  Clinics (Sao Paulo)       Date:  2016-07       Impact factor: 2.365
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.